Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
|
Name |
CAS Number
|
---|---|---|
289-337-4 | 6,6-dibutyl-4,4,8,8-tetraethoxy-3,5,7,9-tetraoxa-4,8-disila-6-stannaundecane | 87735-26-0 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Muta. 2 | H341 | H341 |
GHS08 Dgr |
STOT RE 2; : 2 % ≤ C < 20 % Repr. 1B; : C ≥ .6 % STOT RE 1; : C ≥ 20 % Muta. 2; : C ≥ 2 % |
3 | View details | |||||
Repr. 1B | H360 (Fertility and D...) | H360 | |||||||||
STOT RE 1 | H372 (Spleen, lymphat...) | H372 | |||||||||
Muta. 2 | H341 | H341 |
GHS08 Dgr |
Repr. 1B; : C ≥ .6 % Muta. 2; : C ≥ 2 % STOT RE 2; : 2 % ≤ C < 20 % STOT RE 1; : C ≥ 20 % |
State/Form
|
1 | View details | ||||
Repr. 1B | H360 (oral) (Fertility and D...) | H360 | |||||||||
STOT RE 1 | H372 (Spleen, lymphat...) | H372 | |||||||||
Muta. 2 | H341 | H341 |
GHS08 Dgr |
1 | View details | ||||||
Repr. 1B | H360 | H360 | |||||||||
STOT RE 1 | H372 (spleen) | H372 |
Number of Aggregated Notifications: 3